Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study.

Journal:
Journal of Clinical Oncology
Published:
Affiliations:
29
Authors:
167
Institutions Authors Share
Merck - Rahway, United States of America (USA)
3.000000
0.12
Vall d'Hebron University Hospital (HUVH), ICS, Spain
1.250000
0.05
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
1.000000
0.04
Sanitas University Foundation (Unisanitas), Colombia
1.000000
0.04
Harbin Medical University Cancer Hospital, China
1.000000
0.04
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)
1.000000
0.04
The First Affiliated Hospital, USTC, China
1.000000
0.04
Fundación Arturo López Pérez (FALP), Chile
1.000000
0.04
Yonsei Cancer Hospital, South Korea
1.000000
0.04
Technical University of Munich (TUM), Germany
1.000000
0.04
The People's Liberation Army General Hospital (PLAGH), China
1.000000
0.04
IMAT Oncomedica S.A., Colombia
1.000000
0.04
Centro de Investigación y Manejo del Cáncer (CIMCA), Costa Rica
1.000000
0.04
National Cancer Center Hospital East, Japan
1.000000
0.04
Shanghai East Hospital, Tongji University, China
1.000000
0.04
University Hospitals Leuven (UZ Leuven), Belgium
1.000000
0.04
Nanjing Tianyinshan Hospital, China
1.000000
0.04
National Cancer Center Hospital, Japan
1.000000
0.04
Asan Medical Center (AMC), South Korea
1.000000
0.04
Maria Sklodowska-Curie National Research Institute of Oncology, Poland
1.000000
0.04
UCLA Health, United States of America (USA)
1.000000
0.04
Seoul National University (SNU), South Korea
1.000000
0.04
Hospital Medi-K, Guatemala
0.500000
0.02
Francisco Marroquín University (UFM), Guatemala
0.500000
0.02
IOB Institute of Oncology, Spain
0.250000
0.01
Quirónsalud Barcelona Hospital, Spain
0.250000
0.01
University of Vic - Central University of Catalonia (UVic-UCC), Spain
0.250000
0.01